Browse Items (7 total)
- Tags: *Parkinson's disease
Mechanisms of Gene-Environment Interactions in Parkinson's Disease.
Tags: *Alpha-synuclein, *ATP13A2, *Gene-Environment Interaction, *Genetic Predisposition to Disease, *Manganese, *Paraquat, *Parkinson Disease, *Parkinson's disease, *Rotenone, 2017, Current environmental health reports, Department of Pharmaceutical Sciences, Environmental Exposure/*adverse effects, Fleming Sheila M, Herbicides/adverse effects, Humans, Insecticides/adverse effects, Mutation/genetics, NEOMED College of Pharmacy, Paraquat/adverse effects, Risk Factors, Rotenone/adverse effects
The effect of manganese exposure in Atp13a2-deficient mice.
Tags: *Alpha-synuclein, *Lipofuscin, *Manganese, *Mice, *Parkinson's disease, *Sensorimotor function, 2018, Aga Diana S, Department of Pharmaceutical Sciences, Ekhator Osunde R, Fleming Sheila M, Holden John G, Karkare Swagata, Lemkuhl Andrew, Linn Stephen C, Liou Benjamin, Mullin Elizabeth J, NEOMED College of Pharmacy, Neurotoxicology, Pamphile Shanta, Roth Jerome A, Santiago Nicholas A, Schultheis Patrick J, Shull Gary E, Sun Ying
The effect of manganese exposure in Atp13a2-deficient mice.
Tags: *Alpha-synuclein, *Lipofuscin, *Manganese, *Parkinson's disease, *Sensorimotor function, 2018, Adenosine Triphosphatases/genetics/*metabolism, Aga Diana S, alpha-Synuclein/metabolism, Animal, Animals, Behavior, Brain/*drug effects/*metabolism, Department of Pharmaceutical Sciences, Ekhator Osunde R, Female, Fleming Sheila M, Holden John G, Inbred C57BL, Karkare Swagata, Knockout, Lemkuhl Andrew, Linn Stephen C, Liou Benjamin, Male, Manganese/metabolism/*toxicity, Membrane Proteins/genetics/*metabolism, Mice, Motor Activity, Mullin Elizabeth J, NEOMED College of Pharmacy, Neurotoxicology, Pamphile Shanta, Roth Jerome A, Santiago Nicholas A, Schultheis Patrick J, Shull Gary E, Sun Ying
Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease.
The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6.
Tags: *gp91(phox), *Microglia, *MPTP, *Na(v)1.6, *Neuroinflammation, *Parkinson's disease, *TNF-alpha, *Voltage-gated sodium channels, *Zonisamide, 2018, Department of Pharmaceutical Sciences, Experimental neurology, Gearing Marla, Hossain Muhammad M, NEOMED College of Pharmacy, Reuhl Kenneth, Richardson Jason R, Weig Blair, Wu Long-Jun
The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6.
Tags: *gp91(phox), *Microglia, *MPTP, *Na(v)1.6, *Neuroinflammation, *Parkinson's disease, *TNF-alpha, *Voltage-gated sodium channels, *Zonisamide, 2018, Aged, Animals, Antiparkinson Agents/*pharmacology, Experimental neurology, Female, Gearing Marla, Hossain Muhammad M, Humans, Inbred C57BL, Inflammation/metabolism, Male, Mice, Microglia/drug effects/*metabolism, NAV1.6 Voltage-Gated Sodium Channel/*biosynthesis, Neuroprotective Agents/pharmacology, Parkinsonian Disorders/*metabolism/pathology, Reuhl Kenneth, Richardson Jason R, Weig Blair, Wu Long-Jun, Zonisamide/*pharmacology
The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor.
Tags: *Neuroinflammation, *Parkinson's disease, 1-Methyl-4-phenyl-1, 2, 2018, 3, 6-tetrahydropyridine/pharmacology, Analysis of Variance, Animals, Anti-Inflammatory Agents/*therapeutic use, Astrocyte, Astrocytes/*drug effects, Boyle Alexa M, Budge Kevin M, Case-Control Studies, CD44, Cells, Chemical, Cultured, Cytokines/genetics/metabolism, Databases, Female, Glial Fibrillary Acidic Protein/metabolism, GPNMB, Humans, Hyaluronan Receptors/*metabolism, Inflammation/*drug therapy/etiology, Journal of neuroinflammation, Male, Membrane Glycoproteins/*therapeutic use, Messenger/metabolism, Mice, Neal Matthew L, Neurotoxins/toxicity, Nitric Oxide/metabolism, Parkinson Disease/complications/*pathology, Reactive Oxygen Species/metabolism, Richardson Jason R, RNA, Safadi Fayez F, Signal Transduction/drug effects